Position in SKYE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 42 holders
Holding Since
Jun 2024
9 quarters on record
Common Shares in SKYE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NFSG Corp holds $2,875,353 across 46 Biotechnology names. SKYE ranks #46 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,061 | $1,643,603 | |
| 2 | OMER |
Omeros Corp
|
46,210 | $439,457 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
11,925 | $201,771 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
1,003 | $87,210 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
1,700 | $66,317 | |
| 6 | GLSI |
Greenwich LifeSciences, Inc.
|
2,100 | $49,266 | |
| 7 | VERA |
Vera Therapeutics, Inc.
|
1,000 | $42,910 | |
| 8 | PALI |
Palisade Bio, Inc.
|
20,250 | $42,322 |
All Filings in SKYE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1 | 1 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1 | 1 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1 | 18 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $8 | 18 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9 | 18 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $3 | 18 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6 | 18 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $8 | 18 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $18 | 18 | Shares | Sole | 2024-09-11 | |
| No filing history on record for this holder in this stock. | ||||||